WallStSmart
VTRS

Viatris Inc

NASDAQ: VTRS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$14.97
+1.01% today

Updated 2026-04-29

Market cap
$17.43B
P/E ratio
P/S ratio
1.22x
EPS (TTM)
$-3.00
Dividend yield
3.24%
52W range
$8 – $16
Volume
10.4M

Viatris Inc (VTRS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+7.3%
Last 4 quarters
Revenue YoY growth
+5.0%
Most recent quarter
EPS YoY growth
+5.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+10.9%
2025-08-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-02$0.57+6.6%$14.93$14.89-0.3%
2025-11-06$0.67+8.1%$10.75$10.12-5.9%
2025-08-07$0.62+12.7%$8.75$9.70+10.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.53$0.57+6.6%$3.70B+5.0%
2025-09-30$0.62$0.67+8.1%$3.76B+0.2%
2025-06-30$0.55$0.62+12.7%$3.58B-5.6%
2025-03-31$0.49$0.50+1.6%$3.25B-11.2%
2024-12-31$0.57$0.54-5.6%$3.53B-8.1%
2024-09-30$0.68$0.75+10.3%$3.75B-4.8%
2024-06-30$0.68$0.69+1.5%$3.80B-3.1%
2024-03-31$0.67$0.67+0.0%$3.66B-1.8%
2023-12-31$0.65$0.62-4.6%$3.84B
2023-09-30$0.74$0.79+6.8%$3.94B
2023-06-30$0.71$0.75+5.6%$3.92B
2023-03-31$0.69$0.77+11.6%$3.73B

Frequently asked questions

Has Viatris Inc beaten earnings estimates?
Viatris Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +7.3% over the last 4 quarters.
How does VTRS stock react to earnings?
VTRS stock has moved an average of +1.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Viatris Inc's revenue growth rate?
Viatris Inc reported year-over-year revenue growth of +5.0% in its most recent quarter, with EPS growing +5.6% year-over-year.